bioRxiv · 10.1101/2021.04.30.442148
Myofibroblast transcriptome indicates SFRP2+ fibroblast progenitors in systemic sclerosis skin
Abstract
Skin and lung fibrosis in systemic sclerosis (SSc) is driven by myofibroblasts, alpha-smooth muscle actin expressing cells that arise from a variety of cell types in murine fibrosis models. Utilizing single cell RNA-sequencing to examine the transcriptome changes, we show that SSc dermal myofibroblasts arise from an SFRP2/DPP4-expressing progenitor fibroblast population that globally upregulates expression of transcriptome markers, such as PRSS23 and THBS1. Only a fraction of SSc fibroblasts differentiate into myofibroblasts, as shown by expression of additional markers, SFRP4 and FNDC1. The myofibroblast transcriptome implicates upstream transcription factors that drive myofibroblast differentiation.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Tabib, T., Huang, M. A., Morse, C., Papazoglou, A., Behera, R., Jia, M., Bulik, M., Monier, D. E., Benos, P. V., Chen, W., Domsic, R., Lafyatis, R.. 2021-04-30. Myofibroblast transcriptome indicates SFRP2+ fibroblast progenitors in systemic sclerosis skin. https://doi.org/10.1101/2021.04.30.442148
Cite the original work for its findings. Save a collection to share your selection of sources.